Last reviewed · How we verify
Jiedu Huayu Oral Prescription — Competitive Intelligence Brief
phase 3
Hepatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Jiedu Huayu Oral Prescription (Jiedu Huayu Oral Prescription) — Beijing Tiantan Hospital. Jiedu Huayu Oral Prescription is a traditional Chinese medicine formulation designed to detoxify and resolve blood stasis, potentially improving hepatic fibrosis and cirrhosis outcomes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Jiedu Huayu Oral Prescription TARGET | Jiedu Huayu Oral Prescription | Beijing Tiantan Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Jiedu Huayu Oral Prescription CI watch — RSS
- Jiedu Huayu Oral Prescription CI watch — Atom
- Jiedu Huayu Oral Prescription CI watch — JSON
- Jiedu Huayu Oral Prescription alone — RSS
Cite this brief
Drug Landscape (2026). Jiedu Huayu Oral Prescription — Competitive Intelligence Brief. https://druglandscape.com/ci/jiedu-huayu-oral-prescription. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab